ARGX:NASDAQ
argenx SE - ADR
912,87 US$
arrow_downward
-0,69%(-6,34) 1K
912,87 US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 5-okt, 16:00:02 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoARGX tikeri uchun statistika yaratilmoqda...
Ochish
920,82 US$
Yuqori
923,31 US$
Past
903,50 US$
Bozor kapitali
56,95 mlrd
Oʻrtacha hajm
257,81 ming
Hajmi
0,00
P/E koeffitsiyenti
34,68
52 haftalik eng yuqori
1 072,75 US$
52 haftalik eng past
661,85 US$
Aksiya boʻyicha daromad
26,32 US$
Beta
0,45
Muomaladagi aksiyalar
62,56 mln
Xodimlar soni
2 ming
Ochish
920,82 US$
Yuqori
923,31 US$
Past
903,50 US$
Bozor kapitali
56,95 mlrd
Oʻrtacha hajm
257,81 ming
Hajmi
0,00
P/E koeffitsiyenti
34,68
52 haftalik eng yuqori
1 072,75 US$
52 haftalik eng past
661,85 US$
Aksiya boʻyicha daromad
26,32 US$
Beta
0,45
Muomaladagi aksiyalar
62,56 mln
Xodimlar soni
2 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AD HOC NEWS
·
10 soat oldin
Argenx stock gets fresh VYVGART data before Q3 results
Zacks
·
15 soat oldin
BMY or ARGX: Which Is the Better Value Stock Right Now?
Yahoo Finance UK
·
16 soat oldin
BMY or ARGX: Which Is the Better Value Stock Right Now?
AD HOC NEWS
·
20 soat oldin
argenx presents Vyvgart data: Goldman lifts argenx stock target to EUR 982.00
Profil
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
argenx SE - ADR haqida